Adresse: No 68 Da Tang Road，DaLang Village BaiYun Hu Street，BaiYun District
Telefon: +0086-020-36385415
.
Product Name: RutinSynonym: Rutoside, Vitamin P, ViolaquereitrinSpecification: NF11,DAB10,EP8CAS:153-18-4Molecular Formula: C27H30O16Molecular Weight: 610.51 Appearance: yellowish- needle - crystal (in water)Melting Point : 176-8°C,23D:+13.82°C (ethanol), 20D-39.43 °C (pyridine)Solubility: 1g in 7ml of methanol, 8000ml of water, 200ml of boiling water - UVλ CH3OHmax nm: 258.361; IRνKBr max cm-1: 3400(OH), 1670(C=O), 1620, 1520, 1470(C6H5-)Botanical source: Ruta graveolens L., plant essential oil [2]; Sophora japonica L., main part of fruit [3,4]; Hypericum aseyron L., full plant; Berchemia polyphylla Wall, var leioclada Hand. -Mazz. [5]; Mallotus japonicus Muell.-Arg, leafs [6]; Fagopyrum esculentum Moench seedling.Indications:1. Anti-inflammatory action: apparent suppression of inflammation due to planted wool when the product is injected into abdominal cavity of rat [8]. Sodium rutin sulfate has very strong anti-inflammatory action to edema of rat [9]. 2. Actions like Vitamin P: maintain the strength of blood vessel, reduce its permeability and brittleness; degreasing action to liver fatty infiltration, especially together with glutathione. 3. Antiviral action: best suppression to phlyctenular stomatitis virus at product concentration of 200g/ml [10, 11]. 4. Inhibition of aldehyde reductase: 95% inhibition at a concentration of 10-5M [12], which facilitates the treatment of diabetic cataract. 5. Toxicity: mice, intravenous injection, LD50 at 950mg/kg. 6. Clinical use: for the prevention of intracerebral hemorrhage, hypertension, retinal hemorrhage, purpura and acute hemorrhagic nephrosonephritis; for treatment of chronic tracheitis with effective rate at 84.8% and 98%. Its derivative, troxerutin, or Venoruton, is applied clinically for burn, arthritis, and all kinds of blood vessel diseases. Commodity drug is available in abroad [14], while the drug has been successfully developed in domestic. With Effective rate for the treatment of cerebrovascular diseases is 87.8%; 88% for retinal edema and hemorrhage [3].
Hilfe
Zu Favoriten 
Dem Warenkorb hinzugefügte Favoriten
